International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12787888
Original Research Article
Correlation of Hypotension with Severity of Acute Kidney Injury in Critically Ill Adults
Published
Nov. 16, 2024
Abstract

Background: The correlation between hypotension and acute kidney damage in an intensive care unit context is not entirely understood, despite the fact that the relationship between low blood pressure and kidney function has been thoroughly documented in an experimental setting based on evidence from animals. Based on the MIMIC II database, the current study is to estimate the risk of acute kidney injury (AKI) development in intensive care unit (ICU) patients as a function of both the severity of hypotension and the duration of hypotension.Methods: This is a retrospective comparative study performed in 100 patients admitted in ICU of a tertiary care hospital affiliated with a medical college. The study included all patients admitted in ICU from April 2023 to April 2024 with a myriad of aetiologies. The case records were extracted from the ICU records, and details of demographics, aetiology, intervention, ICU stay, days on ventilator and vitals during ICU stay, amongst other parameters, were recorded in a semistructured pro forma. Results:Mean duration of the hypotension was found to be 5.92 hours in the AKI group, while in the non-AKI group it was 4.32 hours. Mean arterial blood pressure of the AKI group was significantly lower than the non-AKI group (p = 0.0031).Conclusion: Our study indicates that the severity and duration of hypotension are both significant risk factors in AKI development in critically ill patient.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
257 Views
40 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved